3',5'-Cyclic-AMP phosphodiesterase (3.1.4.53)

Industry

CPC
C12Y301/04053

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12YENZYMES C12Y301/00Hydrolases acting on ester bonds (3.1)

Current Industry

C12Y301/040533',5'-Cyclic-AMP phosphodiesterase (3.1.4.53)

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods for treating COPD and other inflammatory c...
- Patent number 11,045,456
- Issue date Jun 29, 2021
- Georgia State University Research Foundation, Inc.
- Jian-Dong Li
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Triazole derivatives and their use as PDE4 activators
- Patent number 10,793,531
- Issue date Oct 6, 2020
- Mironid Limited
- Julia Adam
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
T cells with increased immunosuppression resistance
- Patent number 10,689,620
- Issue date Jun 23, 2020
- Adaptimmune Limited
- Bruno Laugel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazole derivatives and their use as PDE4 activators
- Patent number 10,385,027
- Issue date Aug 20, 2019
- Mironid Limited
- Julia Adam
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
T cells with increased immunosuppression resistance
- Patent number 9,976,121
- Issue date May 22, 2018
- Adaptimmune Limited
- Bruno Laugel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNAi-mediated inhibition of phosphodiesterase type 4 for treatment...
- Patent number 9,765,340
- Issue date Sep 19, 2017
- Arrowhead Pharmaceuticals, Inc.
- John M. Yanni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNAi-mediated inhibition of phosphodiesterase type 4 for treatment...
- Patent number 9,453,220
- Issue date Sep 27, 2016
- Arrowhead Pharmaceuticals, Inc.
- John M. Yanni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNAi-mediated inhibition of phosphodiesterase type 4 for treatment...
- Patent number 8,673,873
- Issue date Mar 18, 2014
- Alcon Research, Ltd.
- John M. Yanni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS
- Publication number 20240368659
- Publication date Nov 7, 2024
- BIOSYNTIA APS
- Carlos Guillermo ACEVEDO-ROCHA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TRIAZOLE DERIVATIVES AND THEIR USE AS PDE4 ACTIVATORS
- Publication number 20200002296
- Publication date Jan 2, 2020
- MIRONID LIMITED
- Julia Adam
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
T Cells With Increased Immunosuppression Resistance
- Publication number 20180298338
- Publication date Oct 18, 2018
- Bruno Laugel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TRIAZOLE DERIVATIVES AND THEIR USE AS PDE4 ACTIVATORS
- Publication number 20180057466
- Publication date Mar 1, 2018
- MIRONID LIMITED
- Julia Adam
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING COPD AND OTHER INFLAMMATORY C...
- Publication number 20180042904
- Publication date Feb 15, 2018
- Georgia State University Research Foundation, Inc
- Jian-Dong Li
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
T Cells with Increased Immunosuppression Resistance
- Publication number 20180010095
- Publication date Jan 11, 2018
- ADAPTIMMUNE LIMITED
- Bruno Laugel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNAi-MEDIATED INHIBITION OF PHOSPHODIESTERASE TYPE 4 FOR TREATMENT...
- Publication number 20140171487
- Publication date Jun 19, 2014
- ALCON RESEARCH, LTD.
- John M. Yanni
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BICYCLIC HETEROARYL INHIBITORS OF PDE4
- Publication number 20130116279
- Publication date May 9, 2013
- KALYPSYS, INC.
- Steven P. Govek
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

3',5'-Cyclic-AMP phosphodiesterase (3.1.4.53)

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Compositions and methods for treating COPD and other inflammatory c...

Triazole derivatives and their use as PDE4 activators

T cells with increased immunosuppression resistance

Triazole derivatives and their use as PDE4 activators

T cells with increased immunosuppression resistance

RNAi-mediated inhibition of phosphodiesterase type 4 for treatment...

RNAi-mediated inhibition of phosphodiesterase type 4 for treatment...

RNAi-mediated inhibition of phosphodiesterase type 4 for treatment...

Patents Applicationslast 30 patents

MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS

TRIAZOLE DERIVATIVES AND THEIR USE AS PDE4 ACTIVATORS

T Cells With Increased Immunosuppression Resistance

TRIAZOLE DERIVATIVES AND THEIR USE AS PDE4 ACTIVATORS

COMPOSITIONS AND METHODS FOR TREATING COPD AND OTHER INFLAMMATORY C...

T Cells with Increased Immunosuppression Resistance

RNAi-MEDIATED INHIBITION OF PHOSPHODIESTERASE TYPE 4 FOR TREATMENT...

BICYCLIC HETEROARYL INHIBITORS OF PDE4